EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹971 Cr | ₹727 Cr | ₹747 Cr | ₹973 Cr | ₹657 Cr |
| Adjustment | ₹552 Cr | ₹543 Cr | ₹492 Cr | ₹399 Cr | ₹582 Cr |
| Changes In working Capital | ₹-424 Cr | ₹51 Cr | ₹-292 Cr | ₹-292 Cr | ₹-335 Cr |
| Cash Flow after changes in Working Capital | ₹1,099 Cr | ₹1,321 Cr | ₹947 Cr | ₹1,079 Cr | ₹905 Cr |
| Cash Flow from Operating Activities | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr | ₹704 Cr |
| Cash Flow from Investing Activities | ₹-94 Cr | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr | ₹-252 Cr |
| Cash Flow from Financing Activities | ₹-814 Cr | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr | ₹-189 Cr |
| Net Cash Inflow / Outflow | ₹-56 Cr | ₹221 Cr | ₹134 Cr | ₹-172 Cr | ₹264 Cr |
| Opening Cash & Cash Equivalents | ₹44 Cr | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr | ₹-609 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | ₹214 Cr | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-2.05 Cr | ₹-2.00 Cr | ₹-0.13 Cr | ₹0.19 Cr | ₹-4.62 Cr |
| Closing Cash & Cash Equivalent | ₹-14 Cr | ₹44 Cr | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr |
Compare Cashflow Statement of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹27,223.7 Cr | -3.6% | -7.6% | 37.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -3.6% |
-7.6% |
37.6% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses